Health Dictionary Find a Doctor

Secondary adrenal insufficiency

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Synonyms and keywords: hypocortisolism; hypocorticism; adrenocortical hypofunction

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Adrenal insufficiency is a condition in which the adrenal glands, located above the kidneys, do not produce adequate amounts of steroid hormones, primarily cortisol, but may also include impaired aldosterone production (a mineralocorticoid) which regulates electrolytes mainly sodium and potassium along side with water retention.[1][2] Craving for salt or salty foods due to the urinary losses of sodium is common.[3]

Adrenal insufficiency can also occur when the hypothalamus or the pituitary gland, both located at the base of the skull, does not make adequate amounts of the hormones that assist in regulating adrenal function.[1][4][5] This is called secondary adrenal insufficiency and is caused by lack of production of ACTH in the pituitary or lack of CRH in the hypothalamus.[6] Accordingly, it is classified in to 2 types, primary adrenal insufficiency and secondary adrenal insufficiency. It must be differentiated from other diseases that may cause hypotension, fatigue, and skin pigmentation. The most potent risk factor in the development of secondary adrenal insufficiency is infections, such as Tuberculosis. Its common complications include hypoglycemia, adrenal crisis,hypovolemic shock and cardiac arrest. Prognosis is generally good in patients with secondary adrenal insufficiency as long as they are on life-time hormonal therapy. The most common symptoms of secondary adrenal insufficiency include Chronic fatigue, weight loss, and visual field defects. The main stay of treatment for secondary adrenal insufficiency is treating the underlying cause. For symptomatic cases, hydrocortisone should be administered. The long-term treatment goal is to maintain normal blood pressure, blood glucose, fluid volume, and a sense of well-being in the patient.

Historical Perspective

Suprarenal glands were discovered by Eustachius in 1563 and were named as Glandulae renis incumbentes. 35th USA President John F. Kennedy had primary Adrenal insufficiency (Addison’s disease).

Classification

Adrenal insufficiency is classified into 2 types based on the level of impairment, primary adrenal insufficiency and secondary adrenal insufficiency.

Pathophysiology

Secondary adrenal insufficiency is caused by the processes occurring outside adrenal glands: pituitary causes, drugs, genetic causes.These disease processes causes the decreased production of adrenocorticotrophic hormone (ACTH).

Causes

Secondary adrenal insufficiency is caused mainly by 4 categories, hypopituitarism, drugs, genetic and other causes. Life-threatening causes include acute withdrawal of steroids, adrenal hemorrhage, Waterhouse-Friderichson syndrome, anti-coagulation and gastroenteritis which causes adrenal crisis. The common causes include chronic steroid therapy and its withdrawal, opiates, causes of pan-hypopituitarism and the less common causes are genetic causes which include combined pituitary hormone deficiency (CPHD), proopiomelanocortin deficiency POMC and isolated ACTH deficiency.

Differentiating Adrenal Insufficiency from other Diseases

Secondary adrenal insufficiency must be differentiated from primary adrenal insufficiency, acute adrenal insufficiency/adrenal crisis, adrenal hemorrhage, congenital adrenal hyperplasia and salt losing nephropathy based on clinical features, such as fatigue and weight loss and laboratory findings.

Epidemiology and Demographics

The prevalence of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than Addison disease. The incidence increases with age; the median age at diagnosis is 60 years. There is no racial predilection.Women are more commonly affected by secondary adrenal insufficiency than male.

Risk Factors

The most potent risk factor in the development of secondary adrenal insufficiency is infections, such as Tuberculosis. Other risk factors include genetic defects of adrenal gland, diabetes, and Vitiligo.

Screening

There is insufficient evidence to recommend routine screening for secondary adrenal insufficiency.

Natural History, Complications and Prognosis

If left untreated, secondary adrenal insufficiency can be life-threatening. Any stressful event or illness can cause a sudden worsening of symptoms, which can lead to severe dehydration and fatally low blood pressure and eventually death from adrenal crisis.Common complications include hypoglycemia, adrenal crisis,hypovolemic shock and cardiac arrest. Prognosis is generally good in patients with secondary adrenal insufficiency as long as they are on life-time hormonal therapy. Patients with secondary adrenal insufficiency must be closely monitored for compliance with medications as acute cases can be life-threating and the mortality rates can go up to 95% in acute crisis.

Diagnosis

History and Symptoms

The most common symptoms of secondary adrenal insufficiency include chronic fatigue, weight loss, and visual field defects.

Physical Examination

Patients with secondary adrenal insufficiency usually appear weak or cushingoid (if the cause is glucocorticoid withdrawal). Physical examination of patients with secondary adrenal insufficiency is usually remarkable for cushingoid features like muscle weakness, buffalo hump. Hypotension may or may not be present. The absence of hyperpigmentation is the hallmark and a distinguishing feature of secondary adrenal insufficiency. Also, the presence of visual field defects like bitemporal hemianopsia indicates a pituitary tumor.

Laboratory Findings

Laboratory findings consistent with the diagnosis of adrenal insufficiency may include eosinophilia,lymphocytosis,normocytic anemia,hyponatremia , mild hypercalcemia, and azotemia. Secondary adrenal insufficiency may be confirmed by dynamic tests such as insulin tolerance test and corticotropin stimulation test (standard and low dose). Adrenal function can be assessed by measuring basal ACTH secretion and ACTH reserve (via Metyrapone stimulation test).

Electrocardiogram

There are no ECG findings associated with secondary adrenal insufficiency.

Chest X Ray

There are no x-ray findings associated with secondary adrenal insufficiency.

CT

CT findings suggestive of chronic adrenal insufficiency may include small and atrophic adrenal gland. CT head findings suggestive of pituitary disorder leading to adrenal insufficiency may include hemorrhage in case of pituitary apoplexy or a mass suggestive of pituitary adenoma or craniopharyngioma.

MRI

MRI is the diagnostic imaging modality used in secondary adrenal insufficiency to assess hypothalamic pituitary adrenal axis. MRI findings suggestive of pituitary abnormality may include a mass suggesting a tumor or empty sella leading to hypopituitarism.

Echocardiography or Ultrasound

There are no ultrasound findings associated with secondary adrenal insufficiency

Other Imaging Findings

There are no other imaging findings associated with secondary adrenal insufficiency.

Other Diagnostic Studies

There are no other diagnostic studies associated with secondary adrenal insufficiency.

Treatment

Medical Therapy

The mainstay of treatment for secondary adrenal insufficiency is treating the underlying cause. For symptomatic cases, hydrocortisone should be administered. The long-term treatment goal is to maintain normal blood pressure, blood glucose, fluid volume, and a sense of well-being in the patient.

Surgery

The mainstay of treatment for secondary adrenal insufficiency is medical therapy. Surgery is usually reserved for tumor of the pituitary which is causing secondary adrenal insufficiency due to mass effect and is resistant to medical therapy.

Primary Prevention

There are no established measures for the primary prevention of secondary adrenal insufficiency. However, the risk can be minimized by preventing hypopituitarism by good obstetric care and minimizing radiation exposure as hypopituitarism is the main cause of secondary adrenal insufficiency. The other effective measures are tapering of steroids and avoidance of the long-term use of opioids.

Secondary Prevention

Effective measures for the secondary prevention of secondary adrenal insufficiency include patient and family members education about risks of hormone replacement therapy and dose adjustments during periods of acute illnesses.

References

  1. 1.0 1.1 Eileen K. Corrigan (2007). “Adrenal Insufficiency (Secondary Addison’s or Addison’s Disease)”. NIH Publication No. 90-3054.
  2. Adrenal+Insufficiency at the US National Library of Medicine Medical Subject Headings (MeSH)
  3. Ten S, New M, Maclaren N (2001). “Clinical review 130: Addison’s disease 2001”. J. Clin. Endocrinol. Metab. 86 (7): 2909–22. doi:10.1210/jc.86.7.2909. PMID 11443143.
  4. Brender E, Lynm C, Glass RM (2005). “JAMA patient page. Adrenal insufficiency”. JAMA. 294 (19): 2528. doi:10.1001/jama.294.19.2528. PMID 16287965.
  5. “Dorlands Medical Dictionary:adrenal insufficiency”.
  6. “Secondary Adrenal Insufficiency: Adrenal Disorders: Merck Manual Professional”.

Template:WH Template:WS

Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Suprarenal glands were discovered by Eustachius in 1563 and were named as Glandulae renis incumbentes. 35th USA President John F. Kennedy had primary Adrenal insufficiency (Addison’s disease).

Historical Perspective

  • Suprarenal glands were discovered by Eustachius in 1563 and were named as Glandulae renis incumbentes.[1]
  • Primary adrenal insufficiency was first discovered by Thomas Addison, an English physician, and scientist, when he described adrenocortical atrophy in 1849 on the autopsy of the adrenal glands of patients, some of which had vitiligo.[2]

Famous Cases

References

  1. Loriaux, D Lynn (2007). “Bartolomeo Eustachi (Eustachius) (1520???1574)”. The Endocrinologist. 17 (4): 195. doi:10.1097/TEN.0b013e318141f6f4. ISSN 1051-2144.
  2. Pearce JM (2004). “Thomas Addison (1793-1860)”. J R Soc Med. 97 (6): 297–300. PMC 1079500. PMID 15173338.
  3. “Endocrinology – E-Book: Adult and Pediatric – J. Larry Jameson, Leslie J. De Groot – Google Books”.


Template:WikiDoc Sources

Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Adrenal insufficiency is classified into 2 types based on the level of impairment, primary adrenal insufficiency and secondary adrenal insufficiency. Secondary adrenal insufficiency may be further classified based on the causes into three types, such as hypopituitary causes, medication causes, and genetic causes.

Classification

Adrenal insufficiency is classified into 2 types based on the level of impairment.

Primary adrenal insufficiency

Secondary adrenal insufficiency

 
 
 
 
 
 
 
 
Adrenal Insufficiency
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary adrenal insufficiency
 
 
 
 
 
 
 
 
 
 
 
Secondary adrenal insufficiency
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Addison’s disease
•Autoimmune adrenalitis
Autoimmune polyendocrine syndrome type 1 and type 2
•Idiopathic
 
 
 
 
 
 
 
 
 
 
Hypopituitarism
•Tumors-Craniopharyngioma
Tuberculosis[1][2]
Histoplasmosis [3]
•Pituitary infarction-Sheehan’s syndrome, pituitary apoplexy
•Removal of pituitary due to metastasis
•Lymphycytic hypophysitis
•Head trauma
•Intracranial artery aneurysms
Drugs
•Chronic high dose steroid
•Opiates- Codeine, Morphine
Genetic causes
•Isolated ACTH deficiency
•POMC deficiency
•Combined Pituitary Hormone Deficiency (CPHD)

References

  1. Al-Mamari A, Balkhair A, Gujjar A, Ben Abid F, Al-Farqani A, Al-Hamadani A, Jain R (2009). “A case of disseminated tuberculosis with adrenal insufficiency”. Sultan Qaboos Univ Med J. 9 (3): 324–7. PMC 3074785. PMID 21509318.
  2. Upadhyay, Jagriti; Sudhindra, Praveen; Abraham, George; Trivedi, Nitin (2014). “Tuberculosis of the Adrenal Gland: A Case Report and Review of the Literature of Infections of the Adrenal Gland”. International Journal of Endocrinology. 2014: 1–7. doi:10.1155/2014/876037. ISSN 1687-8337.
  3. Bhansali A, Das S, Dutta P, Walia R, Nahar U, Singh SK; et al. (2012). “Adrenal histoplasmosis: unusual presentations”. J Assoc Physicians India. 60: 54–8. PMID 23777028.

Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Secondary adrenal insufficiency is caused by the processes occurring outside adrenal glands: pituitary causes, drugs, genetic causes.These disease processes causes the decreased production of adrenocorticotrophic hormone (ACTH).

Pathophysiology

Production of cortisol- Source :NIH, https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease

Pathogenesis

Genetics

Associated Conditions

Gross Pathology

  • The gross pathology features are dependent on the cause. For the gross pathology, when secondary adrenal insufficiency is caused by hypopituitarism, click here.

Microscopic Pathology

  • The microscopic pathology features are dependent on the cause. For the microscopic pathology when the cause is hypopituitarism, click here.
Histopathological image of nonfunctioning pituitary adenoma. Hematoxylin & eosin stain showing basophilic appearance of the cells.
Histopathological image of nonfunctioning pituitary adenoma. Hematoxylin & eosin stain showing basophilic appearance of the cells. Source: By Jensflorian (Own work) [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons

References

Template:WH Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Secondary adrenal insufficiency is caused mainly by four categories, hypopituitarism, drugs, genetic and other causes. Life-threatening causes include acute withdrawal of steroids, adrenal hemorrhage, Waterhouse-Friderichson syndrome, anticoagulation and gastroenteritis which causes adrenal crisis. The common causes include chronic steroid therapy and its withdrawal, opiates, causes of panhypopituitarism and the less common causes are genetic causes which include combined pituitary hormone deficiency (CPHD), proopiomelanocortin deficiency POMC and isolated ACTH deficiency.

Causes

Life-threatening Causes

Life-threatening causes of secondary adrenal insufficiency include causes of acute adrenal crisis/insufficiency:

Common Causes

Secondary adrenal insufficiency may be caused by:

Less Common Causes

Less common causes of secondary adrenal insufficiency include:

Causes by Organ System

Cardiovascular Arteritis, Hypotension, Hemorrhage, Infarction
Chemical / poisoning No underlying causes
Dermatologic POEMS syndrome
Drug Side Effect Aminoglutethimide, Ciclesonide, Cidofovir, Corticosteroid withdrawal, Dexamethasone, Flunisolide, Pembrolizumab,prednisolone, Trilostane
Ear Nose Throat No underlying causes
Endocrine Allgrove syndrome, Achalasia-addisonian syndrome, Adrenal aplasia / adrenal hypoplasia, Adrenal metastases, After surgery of cortisol-secreting tumor, Autoimmune polyendocrine syndrome type 2, Bilateral adrenalectomy , Congenital adrenal hyperplasia, Glucocorticoid deficiency 1, IMAGE syndrome, POEMS syndrome, X-linked adrenal hypoplasia congenita
Environmental No underlying causes
Gastroenterologic Allgrove syndrome, Achalasia-addisonian syndrome, Hemochromatosis
Genetic Congenital adrenal hyperplasia, Cytochrome P450 oxidoreductase deficiency, Glycerol kinase deficiency, Hereditary ACTH resistance, IMAGE syndrome, X-linked adrenal hypoplasia congenita, Combined pituitary hormone deficiency (CPHD), Proopiomelanocortin deficiency (POMC), Isolated ACTH deficiency
Hematologic Anticoagulation, Coagulopathy , Embolus, Leukemia, Lymphoma , Thrombosis
Iatrogenic Iatrogenic, Radiation therapy, Chronic steroid therapy
Infectious Disease AIDS, Blastomycosis, CMV, Coccidiomycosis, Cryptococcosis, Histoplasmosis , Mycobacterium avium intracellulaire (MAI), Sepsis, Syphilis, Toxoplasmosis, Tuberculosis, Waterhouse-Friderichson syndrome
Musculoskeletal / Ortho IMAGE syndrome
Neurologic Adrenoleukodystrophy, Coma, Craniopharyngioma, Panhypopituitarism, POEMS syndrome
Nutritional / Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic Craniopharyngioma, Kaposi’s sarcoma, Leukemia, Lymphoma , pituitary metastasis
Ophthalmologic No underlying causes
Overdose / Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary Sarcoidosis,
Renal / Electrolyte Uremia, Waterhouse-Friderichson syndrome
Rheum / Immune / Allergy Autoimmune, Autoimmune polyendocrine syndrome type 2, Sarcoidosis
Sexual No underlying causes
Trauma Trauma
Urologic No underlying causes
Dental No underlying causes
Miscellaneous Amyloidosis, Idiopathic, Iatrogenic, Radiation therapy, Surgery, Surgical removal of pituitary, Surgical removal of hypothalamus

Causes in Alphabetical Order


References

  1. Ham PB, Cunningham AJ, Mentzer CJ, Ahmad A, Young LS, Abuzeid AM (2015). “Traumatic panhypopituitarism resulting in acute adrenal crisis”. J Trauma Acute Care Surg. 79 (3): 484–9. doi:10.1097/TA.0000000000000771. PMID 26307884.
  2. Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR (2016). “Adrenal Crisis: Still a Deadly Event in the 21st Century”. Am J Med. 129 (3): 339.e1–9. doi:10.1016/j.amjmed.2015.08.021. PMID 26363354.
  3. “www.ucdenver.edu” (PDF).
  4. 4.0 4.1 Huebner A, Yoon SJ, Ozkinay F, Hilscher C, Lee H, Clark AJ; et al. (2000). “Triple A syndrome–clinical aspects and molecular genetics”. Endocr Res. 26 (4): 751–9. PMID 11196451.
  5. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H; et al. (1993). “Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters”. Nature. 361 (6414): 726–30. doi:10.1038/361726a0. PMID 8441467.
  6. Shashidhar PK, Shashikala GV (2012). “Low dose adrenocorticotropic hormone test and adrenal insufficiency in critically ill acquired immunodeficiency syndrome patients”. Indian J Endocrinol Metab. 16 (3): 389–94. doi:10.4103/2230-8210.95680. PMC 3354846. PMID 22629505.
  7. Eledrisi MS, Verghese AC (2001). “Adrenal insufficiency in HIV infection: a review and recommendations”. Am. J. Med. Sci. 321 (2): 137–44. PMID 11217816.
  8. Cocco C, Meloni A, Mariotti S; et al. (2012). “Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1”. Autoimmunity. 45 (6): 485–94. doi:10.3109/08916934.2012.680632. PMID 22506635.
  9. Osa SR, Peterson RE, Roberts RB (1981). “Recovery of adrenal reserve following treatment of disseminated South American blastomycosis”. Am. J. Med. 71 (2): 298–301. PMID 6266250.
  10. Ardalan M, Shoja MM (2009). “Cytomegalovirus-induced adrenal insufficiency in a renal transplant recipient”. Transplant. Proc. 41 (7): 2915–6. doi:10.1016/j.transproceed.2009.07.024. PMID 19765472.
  11. Mihalache A, Lamy O, Waeber G, Schneider A (2007). “[Adrenal insufficiency and hypercalcemia–an unusual presentation]”. Praxis (Bern 1994) (in German). 96 (45): 1761–5. PMID 18050601.
  12. Kawamura M, Miyazaki S, Mashiko S; et al. (1998). “Disseminated cryptococcosis associated with adrenal masses and insufficiency”. Am. J. Med. Sci. 316 (1): 60–4. PMID 9671046.
  13. Turan S, Hughes C, Atay Z; et al. (2012). “An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W)”. J. Clin. Endocrinol. Metab. 97 (5): E771–4. doi:10.1210/jc.2011-2414. PMC 3396854. PMID 22337906.
  14. Francke U, Harper JF, Darras BT; et al. (1987). “Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions”. Am. J. Hum. Genet. 40 (3): 212–27. PMC 1684111. PMID 2883886.
  15. Pedersen-Bjergaard U, Thorsteinsson B, Kirkegaard BC (1996). “[Pituitary function in hemochromatosis]”. Ugeskr. Laeg. (in Danish). 158 (13): 1818–22. PMID 8650756.
  16. Pedreira CC, Savarirayan R, Zacharin MR (2004). “IMAGe syndrome: a complex disorder affecting growth, adrenal and gonadal function, and skeletal development”. J. Pediatr. 144 (2): 274–7. doi:10.1016/j.jpeds.2003.09.052. PMID 14760276.
  17. Weits J, Sprenger HG, Ilic P, van Klingeren B, Elema JD, Steensma JT (1991). “[Mycobacterium avium disease in AIDS patients; diagnosis and therapy]”. Ned Tijdschr Geneeskd (in Dutch; Flemish). 135 (52): 2485–9. PMID 1758516.
  18. Dispenzieri A, Kyle RA, Lacy MQ; et al. (2003). “POEMS syndrome: definitions and long-term outcome”. Blood. 101 (7): 2496–506. doi:10.1182/blood-2002-07-2299. PMID 12456500.
  19. Gostiljac DM, Dordević PB, Maric-zivković J, Canović F (2005). “[Sarcoidosis localized in endocrine glands]”. Med. Pregl. 58 Suppl 1: 25–9. PMID 16526262.


Template:WikiDoc Sources

Differentiating Adrenal Insufficiency from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Secondary adrenal insufficiency must be differentiated from primary adrenal insufficiency, acute adrenal insufficiency/adrenal crisis, adrenal hemorrhage, congenital adrenal hyperplasia and salt losing nephropathy based on clinical features, such as fatigue and weight loss and laboratory findings.

Secondary Adrenal Insufficiency

Secondary adrenal insufficiency must be differentiated from other diseases that may cause hypotension, fatigue, and skin pigmentation.

Acute/

Chronic

Disease Clinical history/findings Causes Laboratory findings Medical therapy
Hypotension Skin

pigmentation/

findings

Fatigue Anorexia/

weightloss

Abdominal pain Muscle

weakness

Other history

findings

Hypo

natremia

Cortisol levels Gold Standard Other
Differentiating amongst adrenal insufficiencies
Chronic Primary adrenal

insufficiency/ Addison’s disease

+ + + + + + + Low Cosyntropin/ ACTH stimulation test
Chronic Secondary adrenal

insufficiency

± + + ± Normal Cosyntropin/ ACTH stimulation test
  • CT scan/ MRI scan showing pituitary causes
Acute Acute adrenal insufficiency/ Acute adrenal crisis ++ ± + + + ± + “Normal to Low Cosyntropin/ ACTH stimulation test
Differentiating Adrenal Insufficiency from other diseases
Adrenal hemorrhage/ Waterhouse Friderichsen syndrome Orthostatic ± + ± +
  • Infection
  1. Sepsis- pneumonia
  2. Waterhouse Friderichsen syndrome- meningococcemia
+ Normal to low Cosyntropin/ ACTH stimulation test
  • CBC (Complete blood count)
  • CT scan
  • Stabilize the patient
  • Treat the underlying cause
Congenital adrenal hyperplasia (CAH) Normal to hypertension ±

(can be indicator of Uncontrolled CAH)[6]

± Low Cosyntropin/ ACTH stimulation test
Syndrome of inappropriate antidiuretic hormone (SIADH) + Normal Water deprivation test
  • Decreased osmolality
  • Euvolemia
  • Sodium in urine typically >20 mEq/
Salt-depletion nephritis/ Salt losing nephropathy + + Flank pain ++[9] High Genetic study <15:1 BUN:CR
Anorexia nervosa + + + + High Psychiatric condition

Adrenal insufficiency must be differentiated from other causes of headache, polyuria and polydypsia.

Disease Causes Symptoms Diagnosis and treatment
SIADH SIADH is a syndrome characterized by excessive release of antidiuretic hormone (ADH or vasopressin) from the posterior pituitary gland or another source. The result is hyponatremia, and sometimes fluid overload
  • Urine sodium concentration>40mmol/litre
Cerebral salt wasting syndrome Cerebral salt wasting syndrome is defined as therenal loss of sodium during intracranial disease leading to hyponatremia and a decrease in extracellular fluid volume The patient is Treatment is
Adrenal insufficiency Adrenal insufficiency

Adrenal insufficiency can be

Common causes of primary adrenal insufficiency:

Chronic disease is characterized by

Acute addisonian crisis is characterized by:

The diagnosis of Addisons disease is made through rapid ACTH administration and measurement of cortisol.

The definitive diagnosis is the cosyntropin or ACTH stimulation test. Acortisol level is obtained before and after administering ACTH. A normal person should show a brisk rise in cortisol level after ACTH administration.


Management: The management of Addison disease involves:

Adrenal crisis:

Hypopituitarism Abnormality in anterior pituitary function

Etiology is as follows:

Signs and symptoms ofhypopituitarism vary, depending on the deficient

hormone and severity of the disorder,some of the symptoms may be as follows:

The treatment of permanent hypopituitarism consists of replacement of the peripheral hormones

Hypothyroidism Hypofunctioning of the thyroid gland due to multifactorial etiology ranging from congenital to autoimmune causes described below: Diagnosis of hypothyroidism is based on blood tests:
Psychogenic polydipsia Also called as primary polydipsia is characterized bypolyuria and polydipsia. Causes are: Evaluation ofpsychiatric patients with polydipsia requires an evaluation for other medical causes of polydipsia, polyuria,hyponatremia, and the syndrome of inappropriate secretion of antidiuretic hormone.
  • The management strategy inpsychiatric patients should include:

References

  1. Patnaik MM, Deshpande AK (2008). “Diagnosis–Addison’s disease secondary to tuberculosis of the adrenal glands”. Clin Med Res. 6 (1): 29. doi:10.3121/cmr.2007.754a. PMC 2442022. PMID 18591375.
  2. Bhattacharjee R, Sharma A, Rays A, Thakur I, Sarkar D, Mandal B, Mookerjee SK, Chatterjee SK, Chowdhury PR (2013). “Addison’s disease presenting with muscle spasm”. J Assoc Physicians India. 61 (9): 675–6. PMID 24772716.
  3. Ray A, Sanyal D (2016). “A rare case of Addison’s disease due to bilateral adrenal histoplasmosis presenting with hypoglycaemia”. J Assoc Physicians India. 64 (1): 45–46. PMID 27727656.
  4. Choudhary N, Aggarwal I, Dutta D, Ghosh AG, Chatterjee G, Chowdhury S (2013). “Acquired perforating dermatosis and Addison’s disease due to disseminated histoplasmosis: Presentation and clinical outcomes”. Dermatoendocrinol. 5 (2): 305–8. doi:10.4161/derm.22677. PMC 3772918. PMID 24194970.
  5. Schimke KE, Greminger P, Brändle M (2009). “Secondary adrenal insufficiency due to opiate therapy – another differential diagnosis worth consideration”. Exp. Clin. Endocrinol. Diabetes. 117 (10): 649–51. doi:10.1055/s-0029-1202851. PMID 19373753.
  6. Patel FB, Newman SA, Norton SA (2016). “Addisonian-Like Hyperpigmentation as an Indicator of Uncontrolled Congenital Adrenal Hyperplasia”. Skinmed. 14 (1): 53–4. PMID 27072733.
  7. Seyberth HW (2016). “Pathophysiology and clinical presentations of salt-losing tubulopathies”. Pediatr. Nephrol. 31 (3): 407–18. doi:10.1007/s00467-015-3143-1. PMID 26178649.
  8. Sayin B (2015). “Tacrolimus-Induced Salt Losing Nephropathy Resolved After Conversion to Everolimus”. Transplant Direct. 1 (9): e37. doi:10.1097/TXD.0000000000000538. PMC 4946484. PMID 27500237.
  9. Yoshioka K, Nishio M, Sano S, Sakurai K, Yamagami K, Yamashita Y (2009). “Development of Severe Hyponatremia due to Salt-Losing Nephropathy after Esophagectomy for Esophageal Cancer”. Case Rep Med. 2009: 241283. doi:10.1155/2009/241283. PMC 2771150. PMID 19888422.

References


Template:WikiDoc Sources

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

The prevalence of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than Addison disease. The incidence increases with age; the median age at diagnosis is 60 years. There is no racial predilection. Women are more commonly affected by secondary adrenal insufficiency than male.

Epidemiology and Demographics

Prevalence

  • The prevalence of secondary adrenal insufficiency is approximately 15-28 per 100,000 individuals worldwide more common than Addison disease.[1]

Age

  • The incidence of secondary adrenal insufficiency increases with age; the median age at diagnosis is 60 years.

Race

  • There is no racial predilection to secondary adrenal insufficiency.

Gender

  • Women are more commonly affected by secondary adrenal insufficiency than male.

References

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

The most potent risk factor in the development of secondary adrenal insufficiency is infections, such as Tuberculosis. Other risk factors include genetic defects of adrenal gland, diabetes, and Vitiligo.

Risk Factors

The following conditions increase the risk of adrenal insufficiency:

References

Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

If left untreated, secondary adrenal insufficiency can be life-threatening. Any stressful event or illness can cause a sudden worsening of symptoms, which can lead to severe dehydration and fatally low blood pressure and eventually death from adrenal crisis. Common complications include hypoglycemia, adrenal crisis, hypovolemic shock and cardiac arrest. Prognosis is generally good in patients with secondary adrenal insufficiency as long as they are on life-time hormonal therapy. Patients with secondary adrenal insufficiency must be closely monitored for compliance with medications as acute cases can be life-threatening and the mortality rates can go up to 95% in acute crisis.

Natural History, Complications, and Prognosis

Natural History

If left untreated, secondary adrenal insufficiency can be life-threatening. Any stressful event or illness can cause a sudden worsening of symptoms, which can lead to severe dehydration and fatally low blood pressure and eventually death from adrenal crisis.

Complications

Complications of secondary adrenal insufficiency include:[1]

Prognosis

  • Prognosis is generally good in patients with secondary adrenal insufficiency as long as they are on life-time hormonal therapy,[2][3] or when the underlying cause is removed.
  • Patients with secondary adrenal insufficiency must be closely monitored for compliance with medications as acute cases can be life-threating and the mortality rates can go up to 95% in acute crisis.
  • For prognosis of secondary adrenal insufficiency where cause is hypopituitarism, click here.

References

  1. Quinkler M (2012). “[Addison’s disease]”. Med Klin Intensivmed Notfmed (in German). 107 (6): 454–9. doi:10.1007/s00063-012-0112-3. PMID 22907517.
  2. Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES (2009). “Normal overall mortality rate in Addison’s disease, but young patients are at risk of premature death”. Eur. J. Endocrinol. 160 (2): 233–7. doi:10.1530/EJE-08-0550. PMID 19011006.
  3. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G (2006). “Premature mortality in patients with Addison’s disease: a population-based study”. J. Clin. Endocrinol. Metab. 91 (12): 4849–53. doi:10.1210/jc.2006-0076. PMID 16968806.

Template:WH Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case#1

Related Chapters


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH